Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Inogen Inc (INGN)

Inogen Inc (INGN)
6.54 x 1 7.36 x 1
Post-market by (Cboe BZX)
7.04 -0.01 (-0.14%) 04/04/25 [NASDAQ]
6.54 x 1 7.36 x 1
Post-market 7.04 unch (unch) 16:20 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.70
Day High
7.10
Open 6.79
Previous Close 7.05 7.05
Volume 554,600 554,600
Avg Vol 335,380 335,380
Stochastic %K 48.59% 48.59%
Weighted Alpha -28.68 -28.68
5-Day Change +0.24 (+3.53%) +0.24 (+3.53%)
52-Week Range 6.14 - 13.33 6.14 - 13.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 189,284
  • Shares Outstanding, K 26,887
  • Annual Sales, $ 335,710 K
  • Annual Income, $ -35,890 K
  • EBIT $ -43 M
  • EBITDA $ -22 M
  • 60-Month Beta 1.48
  • Price/Sales 0.56
  • Price/Cash Flow N/A
  • Price/Book 0.97

Options Overview Details

View History
  • Implied Volatility 107.05% ( +20.87%)
  • Historical Volatility 62.09%
  • IV Percentile 88%
  • IV Rank 51.51%
  • IV High 157.80% on 04/24/24
  • IV Low 53.14% on 01/10/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 818
  • Open Int (30-Day) 1,195

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.52
  • Number of Estimates 3
  • High Estimate -0.40
  • Low Estimate -0.66
  • Prior Year -0.62
  • Growth Rate Est. (year over year) +16.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.52 +7.98%
on 03/31/25
Period Open: 8.03
8.51 -17.27%
on 03/05/25
-0.99 (-12.33%)
since 03/04/25
3-Month
6.52 +7.98%
on 03/31/25
Period Open: 9.62
12.91 -45.47%
on 01/30/25
-2.58 (-26.82%)
since 01/03/25
52-Week
6.14 +14.66%
on 04/08/24
Period Open: 6.65
13.33 -47.19%
on 08/28/24
+0.39 (+5.86%)
since 04/04/24

Most Recent Stories

More News
INGN Stock Gains Following Q4 Earnings Beat, Adjusted Gross Margin Up

Inogen, Inc. INGN incurred an adjusted loss per share of 24 cents for fourth-quarter 2024, which was narrower than the adjusted loss per share of 83 cents in the year-ago period and the Zacks Consensus...

AVAH : 5.03 (-5.45%)
MASI : 144.40 (-5.23%)
INGN : 7.04 (-0.14%)
ATEC : 10.23 (+0.20%)
Inogen: Q4 Earnings Snapshot

Inogen: Q4 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen: Q3 Earnings Snapshot

Inogen: Q3 Earnings Snapshot

INGN : 7.04 (-0.14%)
Can HITI Stock Get a Boost From Bricks-and-Mortar Sales in Q3 Earnings?

High Tide HITI is set to release results for the third quarter of fiscal 2024 on Sept. 16 after market close.The prominent retail cannabis player posted breakeven earnings per share in the last reported...

INGN : 7.04 (-0.14%)
KIDS : 22.70 (-3.90%)
TMDX : 67.67 (-4.64%)
HITI : 1.8100 (-1.09%)
Inogen: Q2 Earnings Snapshot

Inogen: Q2 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen: Q1 Earnings Snapshot

Inogen: Q1 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen: Q4 Earnings Snapshot

Inogen: Q4 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen: Q3 Earnings Snapshot

Inogen: Q3 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen: Q2 Earnings Snapshot

Inogen: Q2 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen: Q1 Earnings Snapshot

Inogen: Q1 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen Announces First Quarter 2023 Financial Results

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31,...

INGN : 7.04 (-0.14%)
Inogen to Report First Quarter 2023 Financial Results on May 4, 2023

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2023 financial results...

INGN : 7.04 (-0.14%)
Inogen to Present at 22nd Annual Needham Virtual Healthcare Conference

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside...

INGN : 7.04 (-0.14%)
Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of...

INGN : 7.04 (-0.14%)
Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside...

INGN : 7.04 (-0.14%)
Inogen: Q4 Earnings Snapshot

Inogen: Q4 Earnings Snapshot

INGN : 7.04 (-0.14%)
Inogen to Provide Strategy Update on February 27, 2023

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a conference call on Monday, February...

INGN : 7.04 (-0.14%)
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results

Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full...

INGN : 7.04 (-0.14%)
Inogen Achieves Regulatory Milestones to Support Current and Future Products

Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has achieved regulatory milestones in the...

INGN : 7.04 (-0.14%)
Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited preliminary revenue results for the fourth...

INGN : 7.04 (-0.14%)

Business Summary

Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen...

See More

Key Turning Points

3rd Resistance Point 7.59
2nd Resistance Point 7.35
1st Resistance Point 7.19
Last Price 7.04
1st Support Level 6.79
2nd Support Level 6.55
3rd Support Level 6.39

See More

52-Week High 13.33
Fibonacci 61.8% 10.58
Fibonacci 50% 9.73
Fibonacci 38.2% 8.89
Last Price 7.04
52-Week Low 6.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades